[ad_1]
Newswise — Using samples collected in Belize with Nancy Simmons from the American Museum of Natural History, CSHL Professors W. Richard McCombie and Adam Siepel and postdoc Armin Scheben sequenced the genomes of the Jamaican fruit bat and Mesoamerican mustached bat. When they compared these sequences to other mammals, the team found that rapid evolution has streamlined bat genomes to defend against infection and cancer. McCombie explains:
“We didn’t know immune system genes were so positively selected in bat genomes. Bats have a number of very unusual things about them. They don’t respond to infections the way we do. In retrospect, it’s not surprising this difference in the immune system may be involved in both the aging and cancer response.”
The Jamaican fruit bat and Mesoamerican mustached bat belong to the world’s most ecologically diverse superfamily of mammals. McCombie, Siepel, and Scheben created complete genomes for both bats using new Oxford Nanopore sequencing technology. They then compared these sequences to 15 other bat and mammal genomes, including humans. This revealed an unknown shift in levels of two inflammatory protein-coding genes called interferon-alpha and -omega.
“Bats have dialed down the immune system’s alarm by shedding genes that produce interferon-alpha,” Scheben explains. “This may be responsible for their high viral tolerance. It prevents overactive immune responses that harm healthy tissue—one of the reasons infections are so damaging to humans.”
They also found that compared to other mammals, bat genomes contain more changes in cancer-related genes, including six that repair DNA and 46 that suppress tumors.
“Our work highlights how immunity and cancer response are deeply interconnected,” Scheben says. “The same immune genes and proteins play important roles in cancer resistance.”
McCombie, Siepel, and Scheben are now exploring how bats’ immune genes are regulated and how they might be expressed in different parts of the body. They hope their work will provide new insights into the links between immunity, aging, and cancer. It may also one day lead to improved treatments.
“There’s still a lot of unknowns,” Siepel says. “Ultimately, we’ll take the work as far as we can and hand off the baton to experts in disease to work toward developing drugs or other therapeutics
[ad_2]
